ProGenis Pharmaceuticals is excited to announce our sponsorship of the First Nucleic Acid Therapeutics Regional Meeting – India 2025, taking place from 18th – 21st February 2025, at the prestigious Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) in Bengaluru, India. This groundbreaking event, supported by a Regional Delivery Grant from the Oligonucleotide Therapeutics Society (OTS), promises to be a significant milestone in advancing the field of nucleic acid therapeutics.
The meeting will bring together leading experts in the field, with plenary talks, invited presentations, young investigator sessions, poster presentations, and engaging panel discussions. Attendees will have the opportunity to network with pioneers in nucleic acid-based solutions and gain insights into the latest advancements and research. In addition, awards will be presented to the best poster sessions, highlighting the innovative work of the next generation of researchers.
At ProGenis, we are especially honoured to announce that our Managing Director and Co-Founder, Dr. Rakesh N. Veedu, will be one of the key speakers at the event. Dr. Veedu’s contribution to the discussion on advancing nucleic acid-based solutions for global health challenges will be invaluable, as he brings decades of expertise in the field to the table. His participation will undoubtedly inspire further collaboration and innovation in the nucleic acid therapeutics community.
Oligonucleotide Therapeutics Society (OTS) and Its Mission
The Oligonucleotide Therapeutics Society (OTS) Annual Meeting is a key platform dedicated to advancing the development of oligonucleotide therapeutics. Through fostering collaboration between academia and industry, OTS aims to accelerate the research and development of oligonucleotide-based therapies, which have the potential to revolutionise treatments for a variety of diseases.
At ProGenis Pharmaceuticals, we are committed to supporting initiatives that foster innovation in the pharmaceutical industry. Our sponsorship of the First Nucleic Acid Therapeutics Regional Meeting is just one way we are contributing to the global conversation around nucleic acid therapeutics and their role in improving global health outcomes.
We look forward to the event in February 2025 and are excited to be part of the ongoing efforts to advance scientific discovery in this critical field.